Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children [0.03%]
母体RSV免疫化和nirsevimab对美国儿童接受医疗救助的RSV的影响及效果
Heidi L Moline,Ayzsa Tannis,Leah Goldstein et al.
Heidi L Moline et al.
Importance: During the 2024-2025 respiratory syncytial virus (RSV) season in the US, nirsevimab and maternal RSV vaccination became widely available to prevent severe RSV disease in infants. Assessments of the real-world ...
Cynthia-Mae M Hunt,Lindsay A Thompson
Cynthia-Mae M Hunt
Josna Jojo
Josna Jojo
Valerie J Watnick
Valerie J Watnick
Nirsevimab Against Hospitalizations and Emergency Department Visits for Lower Respiratory Tract Infection in Infants: A Meta-Analysis [0.03%]
关于尼塞维马b抗体预防婴儿下呼吸道感染住院和急诊就诊的meta分析研究
Dewan Md Sumsuzzman,Congjie Shi,Joanne M Langley et al.
Dewan Md Sumsuzzman et al.
Importance: Nirsevimab, a long-acting monoclonal antibody available since 2023, has demonstrated effectiveness in preventing lower respiratory tract infection (LRTI) caused by respiratory syncytial virus (RSV) in clinical...
Suicidality and Nonsuicidal Self-Injury in Transgender and Gender Diverse Youth: A Systematic Review and Meta-Analysis [0.03%]
关于跨性别和性别多样青年的自杀倾向与非自杀性自伤行为的一项系统评价和荟萃分析
Brae Anne McArthur,Kristine Lyn Pesigan,Lindsay Berg et al.
Brae Anne McArthur et al.
Importance: Transgender and gender diverse (TGD) youth face adversities that increase risks for suicidality and nonsuicidal self-injury (NSSI). However, substantial variability in prevalence rates have been reported acros...
Ashwin K Chetty,Alissa S Chen,James T Nugent
Ashwin K Chetty
Errors in Figures and Tables [0.03%]
图表错误
Published Erratum
JAMA pediatrics. 2025 Dec 22:e255421. DOI:10.1001/jamapediatrics.2025.5421 2025
Mark Christopher Navin,Douglas S Diekema
Mark Christopher Navin
Correction to Patient Page [0.03%]
对患者页的更正
Published Erratum
JAMA pediatrics. 2025 Dec 19:e256223. DOI:10.1001/jamapediatrics.2025.6223 2025